CLÍNICA LAS CONDES S.A.
Registration in the Securities Registry No. 433
Santiago, April 29, 2021
Mrs. Solange Berstain
Chairman
Financial Market Commission
Present.
Ref.: Communicates result Voluntary Early Redemption Option of Series E Bonds.
Madam President:
In compliance with the provisions of Article 9 and second paragraph of Article 10 of Law 18,045, the provisions of General Rule No. 30 of this Commission, duly empowered for this purpose, I come to report the following as an essential fact with respect to the company, its securities and public offer thereof:
In relation to the communication made by Essential Fact dated April 25, 2022, referring to the voluntary early redemption option, with financing and own resources, offered to all holders of Series E Bonds issued under the line of bonds registered in the Securities Registry of its Commission, dated March 16, 2018 under No. 889, currently in circulation, for an amount of 400,000 Development Units for inpaid capital, all in accordance with the provisions of Article 130 of Law No. 18,045, Securities Market Law, in the form, dates and conditions detailed in the Notice published last Monday, April 25, 2022 in the Libero Newspaper, It is hereby reported that the voluntary early redemption option for Series E Bonds was accepted by bondholders, for an amount of 393,500 Development Units, equivalent to 787 Series E Bonds.
Yours faithfully
Ignacio Tapia
General Manager
LEGAL MANAGEMENT
Es Banco de Chile, representatives of Bondholders
Estoril 450
Link to the file in CMFChile: https://www.cmfchile.cl/sitio/aplic/serdoc/ver_sgd.php?s567=043e020747e141958f2886b76c4e91a0VFdwQmVVMXFRVEJOUkVVeVRsUmpNMDVuUFQwPQ==&secuencia=-1&t=1682376108
